microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.

Yoshino H, Yonemori M, Miyamoto K, Tatarano S, Kofuji S, Nohata N, Nakagawa M, Enokida H
Oncotarget. 2017 Mar 28;8(13):20881-20894. doi: 10.18632/oncotarget.14930. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.